Romanelli V A, Howie M B, Myerowitz P D, Zvara D A, Rezaei A, Jackman D L, Sinclair D S, McSweeney T D
Department of Anesthesiology, Ohio State University Hospitals, Columbus 43210.
Crit Care Med. 1993 Aug;21(8):1124-31. doi: 10.1097/00003246-199308000-00009.
In response to an increased frequency of Staphylococcus epidermidis infections in postoperative cardiac surgery patients, antibiotic prophylaxis was changed to include both vancomycin and cefazolin pre- and intraoperatively. Subsequent to the addition of vancomycin prophylaxis, clinical impression and retrospective analysis supported a correlation between vancomycin administration and post-cardiopulmonary bypass norepinephrine use.
A prospective, double-blind, randomized study.
Tertiary care center in a university hospital.
A total of 58 patients undergoing elective coronary artery bypass surgery under high-dose fentanyl anesthesia.
Patients were randomized to receive cefazolin and either vancomycin or normal saline pre-, intra-, and postoperatively in a double-blinded protocol.
Hemodynamic profiles and doses of administered vasoactive agents were calculated and recorded for all patients for both intra- and postoperative time periods. Hypotension consistent with vasodilation was treated with a norepinephrine infusion. The rate and frequency of norepinephrine infusions were tabulated for both groups. Hemodynamic profiles that were obtained after the administration of the initial dose of vancomycin or normal saline and before the induction of general anesthesia and those profiles obtained after the induction of general anesthesia until the initiation of cardiopulmonary bypass showed no difference between groups and no evidence of vasodilation secondary to vancomycin administration. However, subsequent doses of vancomycin in the intra- and postoperative periods were associated with a significantly greater frequency of norepinephrine infusions to maintain normal hemodynamic indices. In the vancomycin group, 50% of patients received a norepinephrine infusion in the intra- and/or postoperative period as compared with 14% in the normal saline group (p < .01). Furthermore, the group of patients who received vancomycin and subsequently required a norepinephrine infusion had significantly lower mean systolic arterial pressure, mean arterial pressure, and systemic vascular resistance as compared with all other groups. There were no differences between groups in the use of vasopressors (other than norepinephrine) or fluid balance.
The results show that a significantly greater number of patients who received vancomycin required a norepinephrine infusion and that, despite norepinephrine infusion therapy, systemic vascular resistance was not normalized in this group of patients. The study supports the conclusion that perioperative administration of vancomycin in cardiac surgery patients may result in hypotension requiring the use of a vasopressor in an attempt to normalize hemodynamic indices.
鉴于心脏手术后患者表皮葡萄球菌感染频率增加,抗生素预防措施改为术中及术前同时使用万古霉素和头孢唑林。在增加万古霉素预防措施后,临床观察和回顾性分析支持万古霉素给药与体外循环后去甲肾上腺素使用之间存在关联。
一项前瞻性、双盲、随机研究。
一所大学医院的三级护理中心。
总共58例在高剂量芬太尼麻醉下接受择期冠状动脉搭桥手术的患者。
患者被随机分配,按照双盲方案在术前、术中和术后接受头孢唑林以及万古霉素或生理盐水。
计算并记录所有患者术中及术后时间段的血流动力学参数和血管活性药物给药剂量。用去甲肾上腺素输注治疗与血管扩张一致的低血压。将两组去甲肾上腺素输注的速率和频率制成表格。在给予初始剂量万古霉素或生理盐水后、全身麻醉诱导前以及全身麻醉诱导后直至体外循环开始前获得的血流动力学参数在两组之间无差异,且无证据表明万古霉素给药会导致血管扩张。然而,术中及术后后续剂量的万古霉素与为维持正常血流动力学指标而进行去甲肾上腺素输注的频率显著增加有关。在万古霉素组中,50%的患者在术中及/或术后接受了去甲肾上腺素输注,而生理盐水组为14%(p < 0.01)。此外,接受万古霉素并随后需要去甲肾上腺素输注的患者组与所有其他组相比,平均收缩压、平均动脉压和全身血管阻力显著更低。两组在使用血管升压药(除去甲肾上腺素外)或液体平衡方面无差异。
结果表明,接受万古霉素治疗的患者中需要去甲肾上腺素输注的人数显著更多,并且尽管进行了去甲肾上腺素输注治疗,但该组患者的全身血管阻力并未恢复正常。该研究支持以下结论:心脏手术患者围手术期使用万古霉素可能导致低血压,需要使用血管升压药以试图使血流动力学指标恢复正常。